Novel modalities - mRNA therapeutics, antibody–drug conjugates, and cell and gene therapies - bring complex formats, methods and analytical requirements to contemporary research. Yet many laboratories adopt siloed approaches to these processes. Save effort, reduce fragmentation and uncover missed insights with effective integrated informatics solutions.
